CLYMClimb Bio, Inc.
- Market cap
- $585.28M
- as of 2026-10-23
- Latest close
- $10.19
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-03-04
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RA Capital Nexus Fund, L.P. | Sep 28 | Sep 30 | M | 10,000 | $3.46 | $34,600 | 10,000 | No | Form 4 |
| RA Capital Nexus Fund, L.P. | Sep 28 | Sep 30 | M | 10,000 | $3.00 | $30,000 | 20,000 | No | Form 4 |
| RA Capital Nexus Fund, L.P. | Sep 28 | Sep 30 | M | 10,000 | $7.89 | $78,900 | 30,000 | No | Form 4 |
| RA Capital Nexus Fund, L.P. | Sep 28 | Sep 30 | M | 40,000 | $1.29 | $51,600 | 70,000 | No | Form 4 |
| RA Capital Nexus Fund, L.P. | Sep 28 | Sep 30 | M · derivative | 10,000 | $3.46 | $34,600 | not reported | No | Form 4 |
| RA Capital Nexus Fund, L.P. | Sep 28 | Sep 30 | M · derivative | 10,000 | $3.00 | $30,000 | not reported | No | Form 4 |
| RA Capital Nexus Fund, L.P. | Sep 28 | Sep 30 | M · derivative | 10,000 | $7.89 | $78,900 | not reported | No | Form 4 |
| RA Capital Nexus Fund, L.P. | Sep 28 | Sep 30 | M · derivative | 40,000 | $1.29 | $51,600 | not reported | No | Form 4 |
| Thomas Stephen Basil | Sep 15 | Sep 17 | S | 100,000 | $13.67 | Sale −$1,367,000 | 467,969 | Yes | Form 4 |
| Celebi Breanna Maurine | Jun 29 | Jul 1 | A · derivative | 70,284 | $13.36 | $938,994 | 70,284 | No | Form 4 |
| Kolchinsky Peter | Jun 29 | Jul 1 | A · derivative | 70,284 | $13.36 | $938,994 | 70,284 | No | Form 4 |
| Brennan AoifePresident and CEO | Jun 29 | Jun 30 | S | 30,902 | $13.17 | Sale −$406,979 | 87,731 | Yes | Form 4 |
| Brennan AoifePresident and CEO | Jun 27 | Jun 30 | M | 68,750 | not reported | not reported | 118,633 | Yes | Form 4 |
| Brennan AoifePresident and CEO | Jun 27 | Jun 30 | M · derivative | 68,750 | $0.00 | $0 | 137,500 | Yes | Form 4 |
| Dunn Judith | Jun 5 | Jun 8 | A · derivative | 40,000 | $10.55 | $422,000 | 40,000 | No | Form 4 |
| Thomas Stephen Basil | Jun 5 | Jun 8 | A · derivative | 40,000 | $10.55 | $422,000 | 40,000 | No | Form 4 |
| Cumbo Alexander | Jun 5 | Jun 8 | A · derivative | 40,000 | $10.55 | $422,000 | 40,000 | No | Form 4 |
| Williams Douglas E | Jun 5 | Jun 8 | A · derivative | 40,000 | $10.55 | $422,000 | 40,000 | No | Form 4 |
| Drapkin Kimberlee C | Jun 5 | Jun 8 | A · derivative | 40,000 | $10.55 | $422,000 | 40,000 | No | Form 4 |
| Levin Andrew David | Jun 5 | Jun 8 | A · derivative | 40,000 | $10.55 | $422,000 | 40,000 | No | Form 4 |
| Kolchinsky Peter | Jun 5 | Jun 8 | A · derivative | 40,000 | $10.55 | $422,000 | 40,000 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Apr 29 | Apr 29 | A · derivative | 2,106,000 | $9.50 | $20,007,000 | 22,546,000 | No | Form 4 |
| Thomas Stephen Basil | Feb 26 | Feb 27 | S | 16,313 | $7.01 | Sale −$114,354 | 154,657 | Yes | Form 4 |
| Thomas Stephen Basil | Feb 25 | Feb 27 | S | 33,687 | $7.00 | Sale −$235,809 | 170,970 | Yes | Form 4 |
| Thomas Stephen Basil | Feb 13 | Feb 17 | S | 10,000 | $5.81 | Sale −$58,100 | 204,657 | Yes | Form 4 |
| Thomas Stephen Basil | Feb 12 | Feb 17 | S | 90,000 | $5.23 | Sale −$470,700 | 214,657 | Yes | Form 4 |
| Driscoll CindySenior Vice President, Finance | Jan 6 | Jan 8 | A · derivative | 100,000 | $3.81 | $381,000 | 100,000 | No | Form 4 |
| ALTSCHULLER SusanChief Financial Officer | Jan 6 | Jan 8 | A · derivative | 142,500 | $3.81 | $542,925 | 142,500 | No | Form 4 |
| Wilson Perrin MeganChief Business Officer | Jan 6 | Jan 8 | A · derivative | 300,000 | $3.81 | $1,143,000 | 300,000 | No | Form 4 |
| Brennan AoifePresident and CEO | Jan 6 | Jan 8 | A · derivative | 700,000 | $3.81 | $2,667,000 | 700,000 | No | Form 4 |
| RA Capital Healthcare Fund LP | Jan 5 | Jan 7 | P | 7,111 | $3.50 | Purchase +$24,889 | 3,403,429 | No | Form 4 |
| Kolchinsky Peter | Dec 12, 2025 | Dec 15, 2025 | P | 101,462 | $2.86 | Purchase +$290,181 | 3,396,318 | No | Form 4 |
| Kolchinsky Peter | Dec 11, 2025 | Dec 15, 2025 | D | 20,440,000 | $0.00 | $0 | 3,081,757 | No | Form 4 |
| Kolchinsky Peter | Dec 11, 2025 | Dec 15, 2025 | P | 213,099 | $2.18 | Purchase +$464,556 | 3,294,856 | No | Form 4 |
| Kolchinsky Peter | Dec 11, 2025 | Dec 15, 2025 | A · derivative | 20,440,000 | not reported | not reported | 20,440,000 | No | Form 4 |
| ALTSCHULLER SusanChief Financial Officer | Oct 1, 2025 | Oct 1, 2025 | A · derivative | 600,000 | $1.97 | $1,182,000 | 600,000 | No | Form 4 |
| Thomas Stephen Basil | Aug 7, 2025 | Aug 11, 2025 | A | 100,375 | $0.00 | $0 | 304,657 | No | Form 4 |
| Brennan AoifePresident and CEO | Jun 30, 2025 | Jul 1, 2025 | S | 20,618 | $1.22 | Sale −$25,154 | 48,132 | Yes | Form 4 |
| Thomas Stephen Basil | Jun 27, 2025 | Jul 1, 2025 | M | 25,094 | not reported | not reported | 204,282 | No | Form 4 |
| Thomas Stephen Basil | Jun 27, 2025 | Jul 1, 2025 | M · derivative | 25,094 | $0.00 | $0 | not reported | No | Form 4 |
| Brennan AoifePresident and CEO | Jun 27, 2025 | Jul 1, 2025 | M | 68,750 | not reported | not reported | 68,750 | Yes | Form 4 |
| Brennan AoifePresident and CEO | Jun 27, 2025 | Jul 1, 2025 | M · derivative | 68,750 | $0.00 | $0 | 206,250 | Yes | Form 4 |
| Pimblett EmilySVP, Finance & CAO | Jun 20, 2025 | Jun 20, 2025 | S | 1,242 | $1.24 | Sale −$1,540 | 18,888 | Yes | Form 4 |
| Pimblett EmilySVP, Finance & CAO | Jun 18, 2025 | Jun 20, 2025 | M | 5,000 | not reported | not reported | 20,130 | Yes | Form 4 |
| Pimblett EmilySVP, Finance & CAO | Jun 18, 2025 | Jun 20, 2025 | M · derivative | 5,000 | $0.00 | $0 | 15,000 | Yes | Form 4 |
| Driscoll CindySenior Vice President, Finance | Jun 17, 2025 | Jun 20, 2025 | A · derivative | 200,000 | $1.20 | $240,000 | 200,000 | No | Form 4 |
| Thomas Stephen Basil | Jun 4, 2025 | Jun 5, 2025 | A · derivative | 40,000 | $1.29 | $51,600 | 40,000 | No | Form 4 |
| Levin Andrew David | Jun 4, 2025 | Jun 5, 2025 | A · derivative | 40,000 | $1.29 | $51,600 | 40,000 | No | Form 4 |
| Williams Douglas E | Jun 4, 2025 | Jun 5, 2025 | A · derivative | 40,000 | $1.29 | $51,600 | 40,000 | No | Form 4 |
| Dunn Judith | Jun 4, 2025 | Jun 5, 2025 | A · derivative | 40,000 | $1.29 | $51,600 | 40,000 | No | Form 4 |
| Cumbo Alexander | Jun 4, 2025 | Jun 5, 2025 | A · derivative | 40,000 | $1.29 | $51,600 | 40,000 | No | Form 4 |
| Drapkin Kimberlee C | Jun 4, 2025 | Jun 5, 2025 | A · derivative | 40,000 | $1.29 | $51,600 | 40,000 | No | Form 4 |
| RA Capital Healthcare Fund LP | Jun 4, 2025 | Jun 5, 2025 | A · derivative | 40,000 | $1.29 | $51,600 | 40,000 | No | Form 4 |
| Williams Douglas E | Mar 31, 2025 | Apr 1, 2025 | A · derivative | 78,873 | $1.22 | $96,225 | 78,873 | No | Form 4 |
| Cumbo Alexander | Mar 28, 2025 | Apr 1, 2025 | A · derivative | 80,000 | $1.28 | $102,400 | 80,000 | No | Form 4 |
| Drapkin Kimberlee C | Mar 28, 2025 | Apr 1, 2025 | A · derivative | 80,000 | $1.28 | $102,400 | 80,000 | No | Form 4 |
| Thomas Stephen Basil | Mar 27, 2025 | Mar 27, 2025 | M | 25,093 | not reported | not reported | 179,188 | No | Form 4 |
| Thomas Stephen Basil | Mar 27, 2025 | Mar 27, 2025 | M · derivative | 25,093 | $0.00 | $0 | 25,094 | No | Form 4 |
| Pimblett EmilySVP, Finance & CAO | Mar 20, 2025 | Mar 20, 2025 | S | 1,199 | $1.31 | Sale −$1,571 | 15,130 | Yes | Form 4 |
| Pimblett EmilySVP, Finance & CAO | Mar 18, 2025 | Mar 20, 2025 | M | 5,000 | not reported | not reported | 16,329 | Yes | Form 4 |
| Pimblett EmilySVP, Finance & CAO | Mar 18, 2025 | Mar 20, 2025 | M · derivative | 5,000 | $0.00 | $0 | 20,000 | Yes | Form 4 |
| Kaplan BrettChief Operating Officer | Jan 13, 2025 | Jan 15, 2025 | A · derivative | 500,000 | $1.92 | $960,000 | 500,000 | No | Form 4 |
| Pimblett EmilySVP, Finance and CAO | Jan 13, 2025 | Jan 15, 2025 | A · derivative | 100,000 | $1.92 | $192,000 | 100,000 | No | Form 4 |
| Brennan AoifePresident and CEO | Jan 13, 2025 | Jan 15, 2025 | A · derivative | 1,150,000 | $1.92 | $2,208,000 | 1,150,000 | No | Form 4 |
| Thomas Stephen Basil | Jan 1, 2025 | Jan 3, 2025 | M | 50,188 | not reported | not reported | 154,095 | No | Form 4 |
| Thomas Stephen Basil | Jan 1, 2025 | Jan 3, 2025 | M · derivative | 50,188 | $0.00 | $0 | 50,187 | No | Form 4 |
| Pimblett EmilyCHIEF ACCOUNTING OFFICER | Dec 19, 2024 | Dec 20, 2024 | S | 1,235 | $2.02 | Sale −$2,495 | 11,329 | Yes | Form 4 |
| Pimblett EmilyCHIEF ACCOUNTING OFFICER | Dec 18, 2024 | Dec 20, 2024 | M | 5,000 | not reported | not reported | 12,564 | Yes | Form 4 |
| Pimblett EmilyCHIEF ACCOUNTING OFFICER | Dec 18, 2024 | Dec 20, 2024 | M · derivative | 5,000 | $0.00 | $0 | 25,000 | Yes | Form 4 |
| Williams Douglas E | Nov 11, 2024 | Nov 12, 2024 | A · derivative | 20,000 | $4.06 | $81,200 | 20,000 | No | Form 4 |
| Williams Douglas E | Nov 11, 2024 | Nov 12, 2024 | A · derivative | 6,291 | $4.06 | $25,541 | 6,291 | No | Form 4 |
| Pimblett EmilyCHIEF ACCOUNTING OFFICER | Sep 20, 2024 | Sep 20, 2024 | S | 1,182 | $8.18 | Sale −$9,669 | 7,573 | Yes | Form 4 |
| Pimblett EmilyCHIEF ACCOUNTING OFFICER | Sep 20, 2024 | Sep 20, 2024 | S | 9 | $8.06 | Sale −$73 | 7,564 | Yes | Form 4 |
| Pimblett EmilyCHIEF ACCOUNTING OFFICER | Sep 18, 2024 | Sep 20, 2024 | M | 5,000 | not reported | not reported | 8,755 | Yes | Form 4 |
| Pimblett EmilyCHIEF ACCOUNTING OFFICER | Sep 18, 2024 | Sep 20, 2024 | M · derivative | 5,000 | $0.00 | $0 | 30,000 | Yes | Form 4 |
| Kaplan BrettChief Operating Officer | Aug 26, 2024 | Aug 26, 2024 | A · derivative | 465,000 | $5.95 | $2,766,750 | 465,000 | No | Form 4 |
| Kaplan BrettChief Operating Officer | Aug 26, 2024 | Aug 26, 2024 | A · derivative | 77,500 | $0.00 | $0 | 77,500 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 22, 2024 | Jul 23, 2024 | S | 39,005 | $8.07 | Sale −$314,770 | 61,317 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 22, 2024 | Jul 23, 2024 | S | 30,000 | $7.98 | Sale −$239,400 | 31,317 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 19, 2024 | Jul 23, 2024 | S | 10,201 | $7.09 | Sale −$72,325 | 150,322 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 19, 2024 | Jul 23, 2024 | S | 50,000 | $7.24 | Sale −$362,000 | 100,322 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 18, 2024 | Jul 19, 2024 | S | 38,576 | $6.93 | Sale −$267,332 | 160,523 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 17, 2024 | Jul 19, 2024 | S | 3,207 | $6.91 | Sale −$22,160 | 199,099 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 16, 2024 | Jul 17, 2024 | S | 50,000 | $7.13 | Sale −$356,500 | 202,306 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 15, 2024 | Jul 16, 2024 | S | 42,377 | $7.01 | Sale −$297,063 | 252,306 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 12, 2024 | Jul 16, 2024 | S | 50,000 | $7.07 | Sale −$353,500 | 294,683 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 11, 2024 | Jul 11, 2024 | S | 50,000 | $7.11 | Sale −$355,500 | 344,683 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 10, 2024 | Jul 11, 2024 | S | 50,000 | $6.83 | Sale −$341,500 | 394,683 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 9, 2024 | Jul 11, 2024 | S | 5,931 | $6.66 | Sale −$39,500 | 444,683 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 5, 2024 | Jul 9, 2024 | S | 12,342 | $7.06 | Sale −$87,135 | 450,614 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 3, 2024 | Jul 3, 2024 | S | 50,000 | $6.76 | Sale −$338,000 | 462,956 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 1, 2024 | Jul 3, 2024 | M | 7,649 | $0.00 | $0 | 512,956 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Jul 1, 2024 | Jul 3, 2024 | M · derivative | 7,649 | $0.00 | $0 | 10,198 | No | Form 4 |
| Kolchinsky Peter | Jun 27, 2024 | Jul 1, 2024 | A | 973,000 | not reported | not reported | 11,572,586 | No | Form 4 |
| Kolchinsky Peter | Jun 27, 2024 | Jul 1, 2024 | A | 2,479,872 | not reported | not reported | 2,479,872 | No | Form 4 |
| Kolchinsky Peter | Jun 27, 2024 | Jul 1, 2024 | A | 1,807,000 | not reported | not reported | 1,807,000 | No | Form 4 |
| Kolchinsky Peter | Jun 27, 2024 | Jul 1, 2024 | P | 11,949,171 | $3.84 | Purchase +$45,884,817 | 23,521,757 | No | Form 4 |
| Kolchinsky Peter | Jun 27, 2024 | Jul 1, 2024 | P | 1,059,375 | $3.84 | Purchase +$4,068,000 | 2,866,375 | No | Form 4 |
| Ratcliffe Liam | Jun 26, 2024 | Jun 28, 2024 | A · derivative | 10,000 | $7.89 | $78,900 | 10,000 | No | Form 4 |
| Tate Simon | Jun 26, 2024 | Jun 28, 2024 | A · derivative | 10,000 | $7.89 | $78,900 | 10,000 | No | Form 4 |
| Dunn Judith | Jun 26, 2024 | Jun 28, 2024 | A · derivative | 10,000 | $7.89 | $78,900 | 10,000 | No | Form 4 |
| Rosenberg Adam Joseph | Jun 26, 2024 | Jun 28, 2024 | A · derivative | 10,000 | $7.89 | $78,900 | 10,000 | No | Form 4 |
| Levin Andrew DavidExecutive Chairman | Jun 26, 2024 | Jun 28, 2024 | A · derivative | 10,000 | $7.89 | $78,900 | 10,000 | No | Form 4 |
| Kolchinsky Peter | Jun 26, 2024 | Jun 28, 2024 | A · derivative | 10,000 | $7.89 | $78,900 | 10,000 | No | Form 4 |
| Thomas Stephen Basil | Jun 27, 2024 | Jun 27, 2024 | A | 103,907 | not reported | not reported | 103,907 | No | Form 4 |
| Thomas Stephen Basil | Jun 27, 2024 | Jun 27, 2024 | A · derivative | 100,375 | $0.00 | $0 | 100,375 | No | Form 4 |
| Brennan AoifePresident and CEO | Jun 27, 2024 | Jun 27, 2024 | A · derivative | 550,000 | $7.53 | $4,141,500 | 550,000 | No | Form 4 |
| Brennan AoifePresident and CEO | Jun 27, 2024 | Jun 27, 2024 | A · derivative | 275,000 | $0.00 | $0 | 275,000 | No | Form 4 |
| Pimblett EmilyCHIEF ACCOUNTING OFFICER | Jun 20, 2024 | Jun 21, 2024 | S | 1,245 | $7.21 | Sale −$8,976 | 3,755 | No | Form 4 |
| Pimblett EmilyCHIEF ACCOUNTING OFFICER | Jun 18, 2024 | Jun 21, 2024 | M | 5,000 | not reported | not reported | 5,000 | No | Form 4 |
| Pimblett EmilyCHIEF ACCOUNTING OFFICER | Jun 18, 2024 | Jun 21, 2024 | M · derivative | 5,000 | $0.00 | $0 | 35,000 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Apr 5, 2024 | Apr 8, 2024 | M | 17,847 | $0.00 | $0 | 505,307 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Apr 5, 2024 | Apr 8, 2024 | M · derivative | 17,847 | $0.00 | $0 | 28,046 | No | Form 4 |
| Pimblett EmilyCHIEF ACCOUNTING OFFICER | Mar 18, 2024 | Mar 20, 2024 | M · derivative | 40,000 | $0.00 | $0 | 40,000 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Sep 20, 2023 | Mar 4, 2024 | M | 5,431 | $0.00 | $0 | 472,163 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Sep 20, 2023 | Mar 4, 2024 | M | 15,297 | $0.00 | $0 | 487,460 | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Sep 20, 2023 | Mar 4, 2024 | M · derivative | 5,431 | $0.00 | $0 | not reported | No | Form 4 |
| Morisset ValerieEVP, R&D AND CSO | Sep 20, 2023 | Mar 4, 2024 | M · derivative | 15,297 | $0.00 | $0 | 45,893 | No | Form 4 |